Clinical Trials
2 trialsNCT02710851 2023-06-15
Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
Xiamen University
Phase 2 Unknown
NCT01735006 2020-02-24
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
Xiamen University
Phase 3 Completed